RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 14.00
+0.50 (3.70%)
Dec 31, 2025, 2:27 PM GMT+1
RUA Life Sciences Market Cap
RUA Life Sciences has a market cap or net worth of 8.69 million as of December 31, 2025. Its market cap has increased by 27.27% in one year.
Market Cap
8.69M
Enterprise Value
6.24M
Revenue
4.11M
Ranking
n/a
PE Ratio
8,688.44
Stock Price
14.00
Market Cap Chart
Since February 26, 1997, RUA Life Sciences's market cap has decreased from 23.82M to 8.69M, a decrease of -63.53%. That is a compound annual growth rate of -3.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 8.69M | 27.27% |
| Dec 31, 2024 | 6.83M | 11.68% |
| Dec 29, 2023 | 6.11M | -43.19% |
| Dec 30, 2022 | 10.76M | -35.33% |
| Dec 31, 2021 | 16.64M | -50.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.40B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |